777 related articles for article (PubMed ID: 23536977)
1. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
Najafi R; Sharifi AM
Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
[TBL] [Abstract][Full Text] [Related]
2. Effect of 17β-estradiol on mediators involved in mesenchymal stromal cell trafficking in cell therapy of diabetes.
Mirzamohammadi S; Aali E; Najafi R; Kamarul T; Mehrabani M; Aminzadeh A; Sharifi AM
Cytotherapy; 2015 Jan; 17(1):46-57. PubMed ID: 25457279
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine promotes mesenchymal stem cell homing in noise-induced injured cochlea through PI3K/AKT pathway.
Peyvandi AA; Abbaszadeh HA; Roozbahany NA; Pourbakht A; Khoshsirat S; Niri HH; Peyvandi H; Niknazar S
Cell Prolif; 2018 Apr; 51(2):e12434. PubMed ID: 29341316
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
Hou Z; Nie C; Si Z; Ma Y
Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.
Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM
Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton's Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study.
Nouri F; Salehinejad P; Nematollahi-Mahani SN; Kamarul T; Zarrindast MR; Sharifi AM
Cell Mol Neurobiol; 2016 Jul; 36(5):689-700. PubMed ID: 26242172
[TBL] [Abstract][Full Text] [Related]
7. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain.
Chu K; Jung KH; Kim SJ; Lee ST; Kim J; Park HK; Song EC; Kim SU; Kim M; Lee SK; Roh JK
Brain Res; 2008 May; 1207():182-92. PubMed ID: 18371939
[TBL] [Abstract][Full Text] [Related]
9. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy.
Oses C; Olivares B; Ezquer M; Acosta C; Bosch P; Donoso M; Léniz P; Ezquer F
PLoS One; 2017; 12(5):e0178011. PubMed ID: 28542352
[TBL] [Abstract][Full Text] [Related]
10. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
[TBL] [Abstract][Full Text] [Related]
11. Deferoxamine preconditioning activated hypoxia-inducible factor-1α and MyD88-dependent Toll-like receptor 4 signaling in intestinal stem cells.
Chen Y; Yang XQ; Tseng BY; Tsai YH; Tseng SH; Lee CH; Yao CL
J Pediatr Surg; 2018 Nov; 53(11):2349-2356. PubMed ID: 29475626
[TBL] [Abstract][Full Text] [Related]
12. Neural cell adhesion molecule modulates mesenchymal stromal cell migration via activation of MAPK/ERK signaling.
Shi Y; Xia YY; Wang L; Liu R; Khoo KS; Feng ZW
Exp Cell Res; 2012 Oct; 318(17):2257-67. PubMed ID: 22683856
[TBL] [Abstract][Full Text] [Related]
13. Injectable hydrogel delivery plus preconditioning of mesenchymal stem cells: exploitation of SDF-1/CXCR4 axis toward enhancing the efficacy of stem cells' homing.
Naderi-Meshkin H; Matin MM; Heirani-Tabasi A; Mirahmadi M; Irfan-Maqsood M; Edalatmanesh MA; Shahriyari M; Ahmadiankia N; Moussavi NS; Bidkhori HR; Bahrami AR
Cell Biol Int; 2016 Jul; 40(7):730-41. PubMed ID: 25825165
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs.
Liu H; Xue W; Ge G; Luo X; Li Y; Xiang H; Ding X; Tian P; Tian X
Biochem Biophys Res Commun; 2010 Oct; 401(4):509-15. PubMed ID: 20869949
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic use of deferoxamine and mesenchymal stem cells in type-1 diabetes: assembling another piece of the jigsaw, in what is a complex puzzle.
Egan CG
Expert Opin Biol Ther; 2013 Sep; 13(9):1221-4. PubMed ID: 23706016
[TBL] [Abstract][Full Text] [Related]
16. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
17. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α is upregulated in human mesenchymal stem cells.
Palomäki S; Pietilä M; Laitinen S; Pesälä J; Sormunen R; Lehenkari P; Koivunen P
Stem Cells; 2013 Sep; 31(9):1902-9. PubMed ID: 23744828
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
[TBL] [Abstract][Full Text] [Related]
20. Deferoxamine loaded titania nanotubes substrates regulate osteogenic and angiogenic differentiation of MSCs via activation of HIF-1α signaling.
Ran Q; Yu Y; Chen W; Shen X; Mu C; Yuan Z; Tao B; Hu Y; Yang W; Cai K
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():44-54. PubMed ID: 30033275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
